Paper19821373
Cannabinoids for Tourette's Syndrome.
Curtis A and 2 others. Cochrane Database Syst Rev, 2009. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Cannabinoids for Tourette's Syndrome. Papers, record 19821373. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19821373
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cannabinoids | Major topic |
| Tourette Syndrome | Major topic |
| Dronabinol | |
| Humans | |
| Randomized Controlled Trials as Topic |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11865128 | Treatment of ADHD in children with tics: a randomized controlled trial. | Neurology | 2002 | https://conductscience.org/library/papers/11865128 | PubMed |
| 2 | 2665687 | Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. | Arch Gen Psychiatry | 1989 | https://conductscience.org/library/papers/2665687 | PubMed |
| 3 | 11157424 | Psychiatric effects of cannabis. | Br J Psychiatry | 2001 | https://conductscience.org/library/papers/11157424 | PubMed |
| 4 | 12716250 | Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. | J Clin Psychiatry | 2003 | https://conductscience.org/library/papers/12716250 | PubMed |
| 5 | 1592779 | The validity of instruments measuring tic severity in Tourette's syndrome. | J Am Acad Child Adolesc Psychiatry | 1992 | https://conductscience.org/library/papers/1592779 | PubMed |
| 6 | 11886028 | Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. | J Am Acad Child Adolesc Psychiatry | 2002 | https://conductscience.org/library/papers/11886028 | PubMed |
| 7 | 11951146 | Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial. | Pharmacopsychiatry | 2002 | https://conductscience.org/library/papers/11951146 | PubMed |
| 8 | 7689702 | Molecular characterization of a peripheral receptor for cannabinoids. | Nature | 1993 | https://conductscience.org/library/papers/7689702 | PubMed |
| 9 | 12849183 | The therapeutic potential of cannabis. | Lancet Neurol | 2003 | https://conductscience.org/library/papers/12849183 | PubMed |
| 10 | 8912803 | A community survey of adverse effects of cannabis use. | Drug Alcohol Depend | 1996 | https://conductscience.org/library/papers/8912803 | PubMed |
| 11 | 2136063 | Treatment of Tourette's syndrome with transdermal clonidine: a pilot study. | J Neuropsychiatry Clin Neurosci | 1990 | https://conductscience.org/library/papers/2136063 | PubMed |
| 12 | 12182961 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. | Pharmacol Ther | 2002 | https://conductscience.org/library/papers/12182961 | PubMed |
| 13 | 22291003 | Effective treatment of Tourette's syndrome with marijuana. | J Psychopharmacol | 1993 | https://conductscience.org/library/papers/22291003 | PubMed |
| 14 | 2165569 | Structure of a cannabinoid receptor and functional expression of the cloned cDNA. | Nature | 1990 | https://conductscience.org/library/papers/2165569 | PubMed |
| 15 | 6371107 | Controlled study of pimozide vs. placebo in Tourette's syndrome. | J Am Acad Child Psychiatry | 1984 | https://conductscience.org/library/papers/6371107 | PubMed |
| 16 | 8440779 | Localization of cannabinoid receptor mRNA in rat brain. | J Comp Neurol | 1993 | https://conductscience.org/library/papers/8440779 | PubMed |
| 17 | 11235929 | Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. | J Clin Psychiatry | 2001 | https://conductscience.org/library/papers/11235929 | PubMed |
| 18 | 11229617 | Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance. | Pharmacopsychiatry | 2001 | https://conductscience.org/library/papers/11229617 | PubMed |
| 19 | 11323066 | The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. | Lancet | 2001 | https://conductscience.org/library/papers/11323066 | PubMed |
| 20 | 12589392 | Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. | Neuropsychopharmacology | 2003 | https://conductscience.org/library/papers/12589392 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42658450 | Ovarian ageing: from biological constraint to emerging therapeutic frontier. | J Assist Reprod Genet | 2026 | https://conductscience.org/library/papers/42658450 | PubMed |
| 42512092 | Chronic Δ9-Tetrahydrocannabinol Inhalation Following Osteoporosis Results in Bone Deficits. | Biomedicines | 2026 | https://conductscience.org/library/papers/42512092 | PubMed |
| 40777575 | A narrative review to guide treatment and care for children with Tourette syndrome. | Brain Disord | 2023 | https://conductscience.org/library/papers/40777575 | PubMed |
| 38985199 | Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38985199 | PubMed |
| 36864363 | Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review. | Eur Child Adolesc Psychiatry | 2024 | https://conductscience.org/library/papers/36864363 | PubMed |
| 35859051 | Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review. | J Neural Transm (Vienna) | 2022 | https://conductscience.org/library/papers/35859051 | PubMed |
| 35401364 | The Efficacy of Cognitive Behavioral Therapy for Tic Disorder: A Meta-Analysis and a Literature Review. | Front Psychol | 2022 | https://conductscience.org/library/papers/35401364 | PubMed |
| 35107785 | Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature. | Curr Neurol Neurosci Rep | 2022 | https://conductscience.org/library/papers/35107785 | PubMed |
| 34436650 | Chronic ∆-9-tetrahydrocannabinol administration delays acquisition of schedule-induced drinking in rats and retains long-lasting effects. | Psychopharmacology (Berl) | 2022 | https://conductscience.org/library/papers/34436650 | PubMed |
| 34430070 | Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray. | Tremor Other Hyperkinet Mov (N Y) | 2021 | https://conductscience.org/library/papers/34430070 | PubMed |
| 32856174 | Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. | Neurotherapeutics | 2020 | https://conductscience.org/library/papers/32856174 | PubMed |
| 32656342 | The Endocannabinoid System: A New Treatment Target for Obsessive Compulsive Disorder? | Cannabis Cannabinoid Res | 2019 | https://conductscience.org/library/papers/32656342 | PubMed |
| 32641910 | A Review of the Current Treatment of Tourette Syndrome. | J Pediatr Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32641910 | PubMed |
| 32020875 | Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews. | BMC Complement Med Ther | 2020 | https://conductscience.org/library/papers/32020875 | PubMed |
| 31955299 | Treatment of tics associated with Tourette syndrome. | J Neural Transm (Vienna) | 2020 | https://conductscience.org/library/papers/31955299 | PubMed |
| 31823819 | Benefits and harms of medical cannabis: a scoping review of systematic reviews. | Syst Rev | 2019 | https://conductscience.org/library/papers/31823819 | PubMed |
| 30977108 | The Potential of Cannabinoid-Based Treatments in Tourette Syndrome. | CNS Drugs | 2019 | https://conductscience.org/library/papers/30977108 | PubMed |
| 30365598 | What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice? | Sao Paulo Med J | 2018 | https://conductscience.org/library/papers/30365598 | PubMed |
| 30090843 | Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration. | Int J Phys Med Rehabil | 2018 | https://conductscience.org/library/papers/30090843 | PubMed |
| 30072700 | Striatal dopaminergic alterations in Tourette's syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies. | Transl Psychiatry | 2018 | https://conductscience.org/library/papers/30072700 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19821373
GET https://conductscience.org/api/papers/v1/19821373/references?page=2